AP- Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. Multiple vaccine candidates must succeed for the world to stamp out the coronavirus pandemic. Moderna is just behind Pfizer and its German partner BioNTech in seeking to begin vaccinations in the U.S. in December. The Massachusetts company revealed the new results Monday. It says of 196 COVID-19 cases so far in its huge U.S. study, only 11 were trial participants who received the real vaccine. Thirty people got severely ill, and all of them got the placebo.
Photo courtesy of AP Photo/Hans Pennink, File
Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.
Posted: Nov 30, 2020 10:34 AM
- Moderna Asking US, European Regulators to OK its Virus Shots
- State Regulators Start “Cannabis Regulators Association”
- Britain, European Union Continue Brexit Trade Talks
- Oxford-AstraZeneca Covid-19 vaccine is safe, European Medicines Agency rules
- Moderna begins study of Covid-19 vaccine in kids
- Corona-Virus Relief Package
- Louisiana regulators: Spread high heating costs across bills
- FDA advisers recommend Moderna's Covid-19 Vaccine, Bringing Second Vaccine Closer to Reality
- Moderna thinks its vaccine will protect against the coronavirus for at least a year
Scroll for more content...